Literature DB >> 2218072

Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats.

B E Hayes1, D E Clarke.   

Abstract

Semicarbazide-sensitive amine oxidase (SSAO) activity was investigated in serum and tissues of streptozotocin diabetic rats. Diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ, 60 mg/kg) and rats were killed at 1, 3, 7, 9, 14, 28 and 56 days after treatment. STZ increased serum glucose and serum SSAO activity at all time points with a maximal increase (2 to 3 fold) at day 7. Kidney SSAO activity showed significant increases on days 9 and 14 (2.5 and 4 fold, respectively). SSAO activity of aorta, lung and pancreas was not changed significantly. Kinetic analysis showed that the elevation in both serum and kidney SSAO activity was due to an increased Vmax with no change in Km. SSAO activity appears to be selectively increased in the serum and kidney of STZ diabetic rats which may be indicative of a relationship between serum SSAO and early renovascular damage in this animal model of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2218072

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  8 in total

1.  The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha.

Authors:  S García-Vicente; A Abella; N Viguerie; A Ros-Baró; M Camps; X Testar; M Palacín; A Zorzano; L Marti
Journal:  J Physiol Biochem       Date:  2005-06       Impact factor: 4.158

2.  Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.

Authors:  P H Yu; D M Zuo
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

3.  Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats.

Authors:  Zs Soltész; T Tábi; A S Halász; M Pálfi; E Kocsis; K Magyar; M Tóth; E Szökö
Journal:  J Neural Transm (Vienna)       Date:  2007-04-13       Impact factor: 3.575

4.  Decreased serum activity of semicarbazide-sensitive amine oxidase (SSAO) in patients treated with second generation antipsychotics: a link to impaired glucose metabolism?

Authors:  Veit Roessner; Annette Weber; Andreas Becker; Georg Beck; Helge Frieling; Stefan Bleich
Journal:  Eur J Clin Pharmacol       Date:  2007-02-28       Impact factor: 2.953

5.  Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.

Authors:  P H Yu
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

6.  Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.

Authors:  A Abella; S García-Vicente; N Viguerie; A Ros-Baró; M Camps; M Palacín; A Zorzano; L Marti
Journal:  Diabetologia       Date:  2004-02-13       Impact factor: 10.122

7.  Increased monoamine oxidase and semicarbazide-sensitive amine oxidase activities in white adipose tissue of obese dogs fed a high-fat diet.

Authors:  E Wanecq; S Bour; P Verwaerde; F Smih; P Valet; C Carpéné
Journal:  J Physiol Biochem       Date:  2006-06       Impact factor: 5.080

8.  HPLC-UV assay for the evaluation of inhibitors of plasma amine oxidase using crude bovine plasma.

Authors:  Kira Mergemeier; Florian Galster; Matthias Lehr
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.